ArriVent BioPharma, Inc.
AVBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001868279
No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 152 institutions reported holding it in 13F filings for Q3 2026, worth $1.53B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Holders of 5% or more of AVBP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ArriVent BioPharma, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Infinitum Asset Management, LLC | 13G/A | 9.90%4.12M shares | 0.00 ppfrom 9.90% | May 15, 20253 filings | Feb 17, 2026 | SEC |
| Suvretta Capital Management, LLC | 13G/A | 9.90%3.41M shares | – | Dec 4, 20242 filings | Aug 13, 2025 | SEC |
| Hillhouse Investment Management, Ltd. | 13G/A | 9.50%3.93M shares | – | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.80%3.18M shares | +1.20 ppfrom 5.60% | Oct 24, 20245 filings | Jul 27, 2026 | SEC |
| OrbiMed Advisors LLC | 13D/A | 5.80%2.88M shares | −1.70 ppfrom 7.50% | Feb 5, 20243 filings | Oct 8, 2026 | SEC |
| FMR LLC | 13G/A | 5.80%2.86M shares | −1.00 ppfrom 6.80% | Nov 12, 20244 filings | Nov 5, 2026 | SEC |
| HBM Healthcare Investments (Cayman) Ltd. | 13G | 5.40%2.20M shares | New | Oct 15, 20251 filing | Oct 15, 2025 | SEC |
| Vivo Opportunity Fund Holdings, L.P. | 13G | 5.00%2.47M shares | New | Oct 13, 20261 filing | Oct 13, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
30 Schedule 13D and 13G filings on ArriVent BioPharma, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 20261:10 PM ET | FMR LLCand 1 other | 13G/A | 5.80%2.86M shares | −1.00 ppfrom 6.80% | Sep 30, 2026 | SEC |
| Oct 13, 20264:01 PM ET | Vivo Opportunity Fund Holdings, L.P.and 5 others | 13G | 5.00%2.47M shares | New | Oct 6, 2026 | SEC |
| Oct 8, 20266:39 PM ET | OrbiMed Advisors LLCand 3 others | 13D/A | 5.80%2.88M shares | −1.70 ppfrom 7.50% | Oct 6, 2026 | SEC |
| Jul 27, 20264:25 PM ET | BlackRock, Inc. | 13G/A | 6.80%3.18M shares | +1.20 ppfrom 5.60% | Jun 30, 2026 | SEC |
| May 6, 202611:00 AM ET | FMR LLCand 1 other | 13G/A | 6.80%3.02M shares | −1.60 ppfrom 8.40% | Mar 31, 2026 | SEC |
| Mar 5, 20266:08 AM ET | Sofinnova Venture Partners IX, L.P.and 4 others | 13G/A | 4.10%1.70M shares | –Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20264:34 PM ET | Infinitum Asset Management, LLCand 2 others | 13G/A | 9.90%4.12M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 17, 20269:00 AM ET | Hillhouse Investment Management, Ltd. | 13G/A | 9.50%3.93M shares | – | Dec 31, 2025 | SEC |
| Jan 30, 20261:28 PM ET | Vanguard Group Inc | 13G/A | 4.52%1.87M shares | −0.48 ppfrom 5.00%Below 5% | Dec 31, 2025 | SEC |
| Jan 21, 202612:30 PM ET | BlackRock, Inc. | 13G | 5.60%2.32M shares | +0.70 ppfrom 4.90% | Dec 31, 2025 | SEC |
| Nov 14, 20254:46 PM ET | Octagon Capital Advisors LPand 4 others | 13G/A | 4.90%1.97M shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 5, 202511:26 AM ET | FMR LLCand 1 other | 13G/A | 8.40%3.41M shares | – | Sep 30, 2025 | SEC |
| Oct 30, 20252:04 PM ET | Vanguard Group Inc | 13G | 5.00%2.03M shares | New | Sep 30, 2025 | SEC |
| Oct 17, 20256:05 PM ET | BlackRock, Inc. | 13G/A | 4.90%2.01M shares | –Below 5% | Sep 30, 2025 | SEC |
| Oct 15, 20254:07 PM ET | HBM Healthcare Investments (Cayman) Ltd. | 13G | 5.40%2.20M shares | New | Oct 8, 2025 | SEC |
| Aug 14, 20254:59 PM ET | Novo Holdings A/S | 13G/A | 4.90%1.87M shares | −0.30 ppfrom 5.20%Below 5% | Jun 30, 2025 | SEC |
| Aug 13, 20257:43 PM ET | OrbiMed Advisors LLCand 3 others | 13D/A | 7.50%3.03M shares | – | Aug 11, 2025 | SEC |
| Aug 13, 20257:29 PM ET | Suvretta Capital Management, LLCand 2 others | 13G/A | 9.90%3.41M shares | – | Jun 30, 2025 | SEC |
| Aug 13, 20256:00 PM ET | Infinitum Asset Management, LLCand 2 others | 13G | 9.90%3.42M shares | +3.80 ppfrom 6.10% | May 1, 2025 | SEC |
| May 15, 20254:36 PM ET | Infinitum Asset Management, LLCand 2 others | 13G | 6.10%2.07M shares | New | May 1, 2025 | SEC |
| Feb 14, 20259:00 PM ET | Novo Holdings A/S | 13G | 5.20%1.75M shares | New | Feb 7, 2025 | SEC |
| Dec 4, 2024 | Suvretta Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Nov 14, 2024 | HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 13GOld format | – | New | – | SEC |
| Nov 12, 2024 | Sofinnova Venture Partners XI, L.P. | 13GOld format | – | New | – | SEC |
| Nov 12, 2024 | FMR LLC | 13GOld format | – | New | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Oct 24, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Oct 11, 2024 | Octagon Capital Advisors LP | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | LAV Fund VI, L.P. | 13GOld format | – | New | – | SEC |
| Feb 5, 2024 | OrbiMed Advisors LLC | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ArriVent BioPharma, Inc. shares.
No Form 144 notices for ArriVent BioPharma, Inc. are on file.